XML 42 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Net Loss from Continuing Operations Before Provision for Income Taxes

Net loss from continuing operations before provision for income taxes are as follows:

 

    December 31,  
    2020     2019  
Domestic   $ (9,358 )     (13,051 )
Foreign     (1,768     815  
Net loss before income tax provision   $ (11,126 )     (12,236 )

Schedule of Current and Deferred Tax Provision (Benefit) for Income Taxes

The provision (benefit) for income taxes consisted of the following (in thousands):

 

    December 31,  
    2020     2019  
Current tax provision:                
U.S. federal   $ -     $ -  
State     -       -  
Foreign     (150 )     148  
Total current provision     (150 )     148  
Deferred tax provision (benefit):                
U.S. federal     -       -  
State     -       -  
Foreign     -       -  
Total deferred provision (benefit)     -       -  
Provision (benefit) for income taxes   $ (150 )   $ 148  

Schedule of Components of Deferred Tax Assets and Liabilities

The primary components of the net deferred tax assets and liabilities as of December 31, 2020 and 2019 were as follows (in thousands):

 

    December 31,  
Deferred tax assets/(liabilities):   2020     2019  
Net operating loss carryforwards   $ 13,958     $ 12,402  
Research and development credit carryforwards     2,306       2,069  
Patents and fixed assets     693       454  
Stock-based compensation     687       659  
Operating lease liability     -       428  
Other, net     184       124  
Operating lease ROU assets     -       (424 )
Valuation allowance     (17,828 )     (15,712 )
Total net deferred tax assets   $ -     $ -  

Schedule of Income Tax Rate Reconciliation

Income taxes differed from the amounts computed by applying the U.S. federal income tax rate indicated to pretax losses from operations as a result of the following:

 

    December 31,  
    2020     2019  
Computed tax benefit at federal statutory rate     21%       21%  
Research and development and other credits     1%       1%  
State tax benefit, net of effect on federal income taxes     2%       5%  
Permanent differences     (2)%       -%  
Tax effect attributable to foreign operations     (2)%       -%  
Change in valuation allowance     (19)%       (28)%  
      1%       (1)%